A New Model for Providing Cell-Free DNA and Risk Assessment for Chromosome Abnormalities in a Public Hospital Setting

Objective. Cell-free DNA (cfDNA) offers highly accurate noninvasive screening for Down syndrome. Incorporating it into routine care is complicated. We present our experience implementing a novel program for cfDNA screening, emphasizing patient education, genetic counseling, and resource management....

Descripción completa

Detalles Bibliográficos
Autores principales: Wallerstein, Robert, Jelks, Andrea, Garabedian, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102090/
https://www.ncbi.nlm.nih.gov/pubmed/25101177
http://dx.doi.org/10.1155/2014/962720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102090/
https://www.ncbi.nlm.nih.gov/pubmed/25101177
http://dx.doi.org/10.1155/2014/962720

Ejemplares similares